Protein Z-related protease inhibitor

3F1S

Protein Z-related protease inhibitor (ZPI), also known as protein Z-dependent protease inhibitor, is a protein that in humans is encoded by the SERPINA10 gene. ZPI is a member of the serpin superfamily of protease inhibitors and plays a critical role in the regulation of coagulation. This protein acts as a cofactor for Protein Z and inhibits certain coagulation factors, particularly Factor Xa and Factor XIa, thereby regulating blood clotting.

Function

Protein Z-related protease inhibitor functions primarily in the coagulation system to prevent excessive clotting. It is a vitamin K-dependent protein, and its activity is enhanced in the presence of Protein Z, which serves as a cofactor. The inhibition of Factor Xa and Factor XIa by ZPI is crucial in maintaining the balance between clot formation and dissolution, preventing conditions such as thrombosis and hemophilia.

Structure

ZPI, like other members of the serpin family, has a characteristic tertiary structure that includes three β-sheets and several α-helices. This structure is essential for its function as a protease inhibitor. The interaction between ZPI and its target proteases involves a conformational change that traps the protease, thereby inhibiting its enzymatic activity.

Genetic Expression

The SERPINA10 gene, located on chromosome 14 (14q32.13), encodes the Protein Z-related protease inhibitor. Variations in this gene can affect the levels and functionality of ZPI, potentially leading to an imbalance in coagulation and an increased risk of clotting disorders.

Clinical Significance

Alterations in the expression or function of ZPI can lead to an increased risk of thrombotic events. Low levels of ZPI have been associated with an increased risk of deep vein thrombosis (DVT) and other coagulation disorders. Conversely, excessive ZPI activity could potentially lead to bleeding disorders due to an inability to form clots effectively.

Research

Ongoing research into ZPI focuses on understanding its precise role in coagulation and its potential as a therapeutic target for treating clotting disorders. Studies are also exploring the genetic factors influencing ZPI levels and activity, which could lead to personalized medicine approaches for managing coagulation disorders.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian